Accessible Treatment

We believe that every patient deserves high-quality treatment. Our sites are development and production centers where we seek to discover high-quality and affordable pharmaceutical products. We provide opportunities for education and training awareness about the importance of health. We work with patient communities and other stakeholders to help patients get the medicines they need. We support various activities to increase the well-being of the wider social environment.

Daily, we recognize patients’ needs and the challenges that arise in the treatment and prevention of diseases and maintaining health. We contribute to increasing the accessibility of treatment in different ways.

Sandoz is committed to playing a key role in achieving global healthcare goals, by pioneering new approaches to drive increased access worldwide. Increasing access to medicine is the basis of our day-to-day business model, but we also run a range of targeted programs to ensure access for those most in need.

Through advanced research to new treatments

Our research and development achievements are accomplished in collaboration with Slovenian academia and renowned Sandoz experts, innovators and international teams. We successfully transfer them to the development and manufacture of high-quality, safe and effective medicines.

At our site in Ljubljana, we have the leading, largest and best-equipped Sandoz Development Center, which carries out almost half of all Sandoz development projects.

Manufacturing a wide range of products to reach as many patients as possible

Our Ljubljana site is a leader in the introduction of new technologies and processes to development and production. It is an expertise center for the Sandoz product network.

In the Aseptics unit, we produce approximately 70 different products and 500 finished products from more than 30 active ingredients. They are dispensed into sterile ampoules and vials, or are produced in the form of non-aseptic solutions, nasal sprays and syrups for markets around the world. We produce biosimilars and complex injectable products in the form of liquid vials and complex nasal sprays.

As one of Sandoz leading global supply centers, it provides medicines to a number of markets around the world.

With the manufacture of potassium clavulanate, which takes place at our site in Lendava, we provide the key ingredient for this leading Sandoz product.

The strategic Sandoz Technical Operations packaging center that operates within our Lendava site, supplies European and global markets with medicinal products from Sandoz production sites around the world.


Innovation and development are at the heart of what we do. We are focusing a lot of our resources on research and high-tech solutions to develop modern medicines and make them more accessible to patients. Our generics and biosimilars are patient-friendly and easy to dose, so they can achieve better patient engagement, ensure more consistent therapeutic concentrations, and result in fewer side effects. We contribute to the awareness of at-risk populations regarding their knowledge of diseases and ways to protect their health through expert advice on our websites, engagement with patient groups, and free information materials in pharmacies and health facilities.